Literature DB >> 7484937

Sugar substitutes: their energy values, bulk characteristics, and potential health benefits.

G V Levin1, L R Zehner, J P Saunders, J R Beadle.   

Abstract

Restriction of dietary energy extends life and reduces incidences of disease in animals. These benefits would likely extend to humans. However, diet restriction in animals imposes reductions of 30-50% in food intake, which is probably unacceptable to humans. Low-energy sweeteners used in beverages offer minor reductions in energy intake. However, they lack the bulk required for baked goods and other sugar-rich foods. Full-bulk sweeteners providing about one-half the energy of sugar are under development for such uses. Laxation limits their acceptable dose. Even within such limitations, they can help achieve the health benefits for humans indicated by diet restriction. D-Tagatose, a new candidate sweetener, is nearly as sweet as sucrose and has the bulk of sucrose, yet provides zero available energy. We discuss its potential contribution to human diet restriction along with its specific effect in delaying the aging effects of glycosylation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7484937     DOI: 10.1093/ajcn/62.5.1161S

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  27 in total

1.  Overexpression, crystallization and preliminary X-ray crystallographic analysis of D-ribose-5-phosphate isomerase from Clostridium thermocellum.

Authors:  Junho Jung; Soo Jin Yeom; Jisun Kim; Jin Kwang Kim; Sampath Natarajan; Yeh Jin Ahn; Sang Boem Lim; Deok Kun Oh; Lin Woo Kang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-10-30

2.  Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability.

Authors:  Hui Gao; Eshita Khera; Jung-Kul Lee; Fei Wen
Journal:  J Vis Exp       Date:  2016-04-22       Impact factor: 1.355

3.  Crystallization and preliminary X-ray crystallographic analysis of L-arabinose isomerase from thermophilic Geobacillus kaustophilus.

Authors:  Thinh-Phat Cao; Jin Myung Choi; Sang-Jae Lee; Yong-Jik Lee; Sung-Keun Lee; Youngsoo Jun; Dong-Woo Lee; Sung Haeng Lee
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2013-12-24       Impact factor: 1.056

4.  Synthesis of rare sugars with L-fuculose-1-phosphate aldolase (FucA) from Thermus thermophilus HB8.

Authors:  Zijie Li; Li Cai; Qingsheng Qi; Thomas J Styslinger; Guohui Zhao; Peng George Wang
Journal:  Bioorg Med Chem Lett       Date:  2011-03-23       Impact factor: 2.823

5.  Characterization of a thermoacidophilic L-arabinose isomerase from Alicyclobacillus acidocaldarius: role of Lys-269 in pH optimum.

Authors:  Sang-Jae Lee; Dong-Woo Lee; Eun-Ah Choe; Young-Ho Hong; Seong-Bo Kim; Byoung-Chan Kim; Yu-Ryang Pyun
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

6.  DDDAS Design of Drug Interventions for the Treatment of Dyslipidemia in ApoE-/- Mice.

Authors:  Brittney Metts; Sean Thatcher; Eboni Lewis; Mike Karounos; Lisa Cassis; Rebecca Smith; Robert A Lodder
Journal:  J Dev Drugs       Date:  2013-10

7.  In vivo selection for the directed evolution of L-rhamnulose aldolase from L-rhamnulose-1-phosphate aldolase (RhaD).

Authors:  Masakazu Sugiyama; Zhangyong Hong; William A Greenberg; Chi-Huey Wong
Journal:  Bioorg Med Chem       Date:  2007-06-02       Impact factor: 3.641

8.  Development of novel sugar isomerases by optimization of active sites in phosphosugar isomerases for monosaccharides.

Authors:  Soo-Jin Yeom; Yeong-Su Kim; Deok-Kun Oh
Journal:  Appl Environ Microbiol       Date:  2012-11-30       Impact factor: 4.792

Review 9.  Artificial sweeteners - a review.

Authors:  Sanchari Chattopadhyay; Utpal Raychaudhuri; Runu Chakraborty
Journal:  J Food Sci Technol       Date:  2011-10-21       Impact factor: 2.701

10.  Concerted proton transfer mechanism of Clostridium thermocellum ribose-5-phosphate isomerase.

Authors:  Jun Wang; Weitao Yang
Journal:  J Phys Chem B       Date:  2013-08-02       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.